Prognostic Value of Myocardial T1 Mapping for Predicting Adverse Events in Hypertrophic Cardiomyopathy
Circulation: Cardiovascular Imaging · 2025-03 · 18 (3)
DOI: 10.1161/circimaging.124.017174 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation: Cardiovascular Imaging, 2025-03. Verfasst von Jie Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology (J.W., W.L., L.P., W.Q., Y.X., Y.C.), West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Magnetic Resonance Imaging, Cine, Heart Failure, Myocardium. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Themen: Patientensicherheit
Abstract (Originalsprache)
BACKGROUND: In patients with hypertrophic cardiomyopathy, the prognostic value of myocardial T1 and extracellular volume fraction for adverse cardiovascular events has not been well defined. METHODS: A total of 663 consecutive participants with hypertrophic cardiomyopathy who underwent 3T cardiovascular magnetic resonance were recruited. The follow-up end points included heart failure (HF)-related death, HF hospitalization, and sudden cardiac death or aborted sudden cardiac death. RESULTS: On Cox proportional hazards regression multivariable analyses, global native T1 excluding late gadolinium enhancement areas (hazard ratio [HR], 1.04 [95% CI, 0.99–1.09]; P =0.094) and global extracellular volume fraction excluding late gadolinium enhancement (HR, 1.02 [95% CI, 0.95–1.10]; P =0.565) were not associated with sudden cardiac death. Conversely, global native T1 (HR, 1.08 per 10 ms increase [95% CI, 1.02–1.16], P =0.014; HR, 1.05 per 10 ms increase [95% CI, 1.01–1.09]; P =0.009) and global extracellular volume fraction (HR, 1.23 per 1% increase [95% CI, 1.11–1.36], P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology (J.W., W.L., L.P., W.Q., Y.X., Y.C.), West China Hospital, Sichuan University, Chengdu, China.
- Cardiac Imaging and Target Therapy Lab (J.W., Y.C.), West China Hospital, Sichuan University, Chengdu, China.
- College of Medical and Dental Sciences, Institute of Cancer and Genomic Sciences (J.W., G.V.G.), University of Birmingham, United Kingdom.
- Division of Informatics, Imaging and Data Sciences, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, United Kingdom (J.Z.).
- Department of Geriatrics (K.W.), West China Hospital, Sichuan University, Chengdu, China.
- Center for Health Data Sciences (G.V.G.), University of Birmingham, United Kingdom.
ORCID-Profile: Jie Wang, Lutong Pu, Yuanwei Xu, Ke Wan, Georgios V Gkoutos, Yuchi Han, Yucheng Chen
Zitieren
APA
Wang, J., Zhang, J., Liu, W., Pu, L., Qi, W., Xu, Y., Wan, K., Gkoutos, G. V., Han, Y., & Chen, Y. (2025). Prognostic Value of Myocardial T1 Mapping for Predicting Adverse Events in Hypertrophic Cardiomyopathy. Circulation: Cardiovascular Imaging, 18(3). https://doi.org/10.1161/circimaging.124.017174
Vancouver
Wang J, Zhang J, Liu W, Pu L, Qi W, Xu Y, et al. Prognostic Value of Myocardial T1 Mapping for Predicting Adverse Events in Hypertrophic Cardiomyopathy. Circulation: Cardiovascular Imaging. 2025;18(3). doi:10.1161/circimaging.124.017174
BibTeX
@article{Wang2025,
author = {Wang, Jie and Zhang, Jinquan and Liu, Wei and Pu, Lutong and Qi, Weitang and Xu, Yuanwei and Wan, Ke and Gkoutos, Georgios V and Han, Yuchi and Chen, Yucheng},
title = {Prognostic Value of Myocardial T1 Mapping for Predicting Adverse Events in Hypertrophic Cardiomyopathy},
journal = {Circulation: Cardiovascular Imaging},
year = {2025},
volume = {18},
number = {3},
doi = {10.1161/circimaging.124.017174}
}
EUVIMED